NYSE:MLSS
Milestone Scientific Stock News
$0.650
-0.0460 (-6.61%)
At Close: May 03, 2024
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
11:45am, Thursday, 28'th Mar 2024
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
08:30am, Friday, 10'th Nov 2023
ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
12:41pm, Tuesday, 15'th Aug 2023
Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Pet
Milestone Scientific: Buy For The $4 Billion Total Addressable Market
06:41pm, Thursday, 15'th Jun 2023
Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer local anesthesia called SingleTooth Anesthesia. T
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
11:00am, Thursday, 15'th Jun 2023
ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today a
Milestone Scientific: Sales Could Start To Snowball
11:52pm, Saturday, 10'th Jun 2023
The shift to online sales in their dental business produced unexpectedly fast results with revenue and gross margin up sharply and more to come. Most if not all of the pieces necessary for CompuFlo sa
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
11:00am, Friday, 05'th May 2023
ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, tod
Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript
07:34pm, Friday, 31'st Mar 2023
Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
08:30am, Wednesday, 29'th Mar 2023
ROSELAND, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t
Milestone Scientific Inc. (MLSS) Q3 2022 Earnings Call Transcript
10:26am, Tuesday, 15'th Nov 2022
Milestone Scientific Inc. (NYSE:MLSS ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer C
Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th
09:00am, Thursday, 06'th Oct 2022
ROSELAND, NJ / ACCESSWIRE / October 6, 2022 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injection
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q2 2022 Results - Earnings Call Transcript
11:58am, Tuesday, 16'th Aug 2022
Milestone Scientific Inc. (NYSE:MLSS ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Commu
Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call
08:30am, Friday, 12'th Aug 2022
ROSELAND, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q1 2022 Results - Earnings Call Transcript
11:48am, Tuesday, 17'th May 2022
Milestone Scientific Inc. (NYSE:MLSS ) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communic
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
11:00am, Friday, 13'th May 2022
ROSELAND, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, tod
